Johnson & Johnson (JNJ)
  • CONTENT
Johnson & Johnson (JNJ)
Johnson & Johnson (JNJ)
Legal battle against opioid crisis heats up
Oklahoma Attorney General Mike Hunter will hold a press conference today to announce a "breaking development" in a multibillion-dollar lawsuit accusing OxyContin maker Purdue Pharma, J&J (NYSE: JNJ ) and Teva (NYSE: TEVA ) of helping fuel an opioid epidemic in the state. More news on: …
My Wife's Freaky Concentrated Market-Crushing U.S. Dividend Growth Portfolio
My readers will know that I skimmed 15 of the largest cap Dividend Achievers. Here's Buying Dividend Growth Stocks Without Looking . The 15 companies that I bought are 3M (NYSE: MMM ), Pepsi (NASDAQ: PEP ), CVS Health Corporation (NYSE: CVS ), Walmart (NYSE: WMT ), Johnson & Johnson (N…
Johnson and Johnson (JNJ) earnings preview: will increasing competition slow down the growth?
Johnson & Johnson (JNJ) is expected to report earnings on July 17 before market open. What are the JNJ earnings expectations? What news will the market be watching out for?
AbbVie (ABBV): Will The Stock Recover?
ABBV diverted the Rova-T program today—and that led to its stock price fall by 13%. When will the stock bounce back?